Publication-grade Systematic Literature Reviews (SLR), quantitative Meta-Analyses, and high-impact peer-reviewed manuscripts conforming to PRISMA, Cochrane, and ICMJE guidelines.
Publishing in top-tier medical journals (Q1/Q2 impact factor) and supporting Health Technology Assessments (HTA) requires more than raw data; it demands immaculate research methodology, reproducible literature synthesis, and strict adherence to international publication ethics (ICMJE, GPP4, and COPE).
Kensai Health provides comprehensive evidence synthesis and medical publication services backed by decades of biopharma, CRO, and academic research rigor. We support biopharma sponsors, academic consortia, and clinical investigators from initial protocol conceptualization through peer-review acceptance. We synthesize vast clinical datasets into authoritative systematic reviews, quantitative meta-analyses, and compelling trial manuscripts that withstand intense scientific scrutiny.Complete manuscript authoring and editing for primary clinical trial results, retrospective cohort studies, and secondary post-hoc analyses. We ensure adherence to target journal Instructions for Authors, ICMJE criteria, and EQUATOR guidelines (CONSORT, STROBE).
Exhaustive, reproducible systematic reviews conforming to PRISMA 2020 guidelines and Cochrane Handbook methodologies. We build sensitive database search algorithms across PubMed, Embase, Scopus, Web of Science, and Cochrane Central.
Pooling trial data across published studies to evaluate overall treatment effect sizes, odds ratios, hazard ratios, and relative risks. We construct publication-ready forest plots and funnel plots to assess publication bias.
Demonstrated scholarly authority across digital therapeutics, clinical trials, and medical communication standards.